Partial
Mostly Aligned
Patient Risk:
Moderate
Summary
Many adverse-effect and iPLEDGE/pregnancy statements are supported by the provided Medication Guide/label excerpts (e.g., dry lips/nose, dry eyes, lab abnormalities, psychiatric effects, decreased night vision, pseudotumor cerebri warning signs, vision/weakness, yellowing/dark urine, pancreatitis warning to stop). However, several symptom-specific claims and patient-action/manage-it statements are not supported by the supplied label text (e.g., irritation, sun sensitivity/sunburn, artificial tears/emollients/sunscreen for dryness, dehydration/fatigue, blistering/peeling linkage, nausea/vomiting+severe headache to specific escalation, depression-related escalation to emergency care, and several dose/duration/liver-condition risk-modifier assertions).
Category Scores
Accurate Statements
Isotretinoin can cause dry skin and dryness of the lips and nose (chapped lips, dry nose).
Medication Guide: “dry skin… chapped lips… dry eyes, and dry nose” (INV-d60a32dc-d66e-4be3-95b5-36c5e4816591)
Isotretinoin can cause dry eyes.
Medication Guide and label excerpts: “dry eyes” (INV-d60a32dc-d66e-4be3-95b5-36c5e4816591); “dryness of the eyes” (INV-c0a42993-cf0e-4d4b-bfea-e0bc8de3bd30)
Isotretinoin can cause lab test changes including elevated triglycerides, elevated cholesterol, and liver enzyme elevations.
Lipids: “Elevations of serum triglycerides… increase in cholesterol levels” (INV-8d2cff4f-d7f2-4b51-8e0f-10085d345095); Hepatotoxicity: “mild to moderate elevations of liver enzymes” (INV-aa98758e-7678-4d13-8113-9b5afc998f04); Lab tests monitoring (INV-d2c7c830-2f87-4782-ae96-33278d848285)
Severe birth defects are an extremely high risk if pregnancy occurs while taking isotretinoin.
Contraindications/Warn: “extremely high risk that severe birth defects will result if pregnancy occurs…” (INV-2ebdc530-791e-4ba3-a959-3caf41cf7a15); Medication Guide: “Sotret causes severe birth defects” (INV-9a1286c1-454c-4284-bb93-9ba5f7a3952f)
Isotretinoin requires strict pregnancy-prevention rules under the iPLEDGE program with specific timing (not pregnant before, during, and after).
Special prescribing requirements/iPLEDGE (INV-6b726997-fbf8-4680-a985-d173a1576157; INV-32a32cb0-4da5-48e7-b83b-73759e288d33) and Medication Guide timing “for 1 month before… while taking… for 1 month after stopping” (INV-9b9360ad-c1b7-45ec-913a-24dde738edd0)
Isotretinoin can cause vision/eye problems and decreased night vision; visual problems should be monitored and patients with difficulties should discontinue and have an ophthalmologic exam.
Vision impairment monitoring (INV-eff24869-8cbb-4a7d-9725-9e0aa3b382f5); Decreased night vision warning (INV-b9d1d3b6-819b-4792-8811-c0734c2732d3); Medication Guide “see in the dark… blurred vision… vision problems” (INV-e3f663c7-6ff3-4d79-9a4c-89f92f760990; INV-48ca7050-2e81-4a42-92c5-6d7f6a38886a)
Isotretinoin can cause depression/suicidal ideation and other psychiatric/behavioral changes; patients/family should contact the prescriber if these occur.
Psychiatric Disorders warning (INV-6fa11bbd-9ae1-449e-983a-e6c99fef62d0); Medication Guide includes suicidal thoughts and stop/call right away instructions (INV-b7809616-f745-41b0-a0de-325407150c73; INV-f71fc622-56b9-4fb5-8f41-d8aa6f49b6d9)
Isotretinoin can be associated with pseudotumor cerebri warning signs including headache, nausea/vomiting, and visual disturbances; patients with symptoms should be screened and told to discontinue and be referred to a neurologist.
Pseudotumor cerebri section (INV-664da432-dd85-445b-bb62-87970ace9be3)
Isotretinoin can cause weakness and may require stopping and contacting the doctor if muscle weakness occurs.
Neurological list includes “weakness” (INV-4b44809b-8a71-4359-a49b-76b6481c471a); Medication Guide: “Stop Sotret and call your doctor right away if you have muscle weakness.” (INV-e542234d-d974-4378-b58b-ecf868138907)
Isotretinoin can cause yellowing of skin/eyes and dark urine; these require stopping and calling the doctor.
Medication Guide includes “yellowing of your skin or eyes” and “dark urine” in stop/call list (INV-48ca7050-2e81-4a42-92c5-6d7f6a38886a)
Isotretinoin can be associated with acute pancreatitis; symptoms of pancreatitis warrant stopping the drug.
Pancreatitis section: “Sotret should be stopped… if symptoms of pancreatitis occur” (INV-3f994619-644c-4319-8b4d-a8f730359910); Medication Guide stomach-area includes liver/pancreas and stop/call symptoms (INV-48ca7050-2e81-4a42-92c5-6d7f6a38886a)
Isotretinoin lab monitoring may be required for liver function tests and lipids including triglycerides.
Laboratory Tests: “Liver Function Tests” and “Lipids… fasting… triglycerides” with weekly/biweekly intervals (INV-d2c7c830-2f87-4782-ae96-33278d848285)
Taking vitamin A supplements with isotretinoin can increase the chance of additive toxicity; vitamin A supplements should be avoided.
Drug Interactions: “advised against taking vitamin supplements containing vitamin A to avoid additive toxic effects” (INV-fa7d38ec-a74d-4968-b3aa-8f2ce40ecafc); Medication Guide about increased chance of side effects (INV-ff8826e2-b2f7-4281-90a0-ec23dea9f21e)
If there is any possibility of pregnancy while taking isotretinoin, the prescriber should be contacted promptly / pregnancy while taking Sotret requires stopping immediately and calling the doctor.
Medication Guide: “If you get pregnant while taking Sotret, stop taking it right away and call your doctor.” (INV-b7809616-f745-41b0-a0de-325407150c73); pregnancy restrictions/timing (INV-9b9360ad-c1b7-45ec-913a-24dde738edd0)
All patients experiencing visual difficulties should discontinue Sotret and have an ophthalmological examination.
Vision impairment section (INV-eff24869-8cbb-4a7d-9725-9e0aa3b382f5)
Unsupported Statements
Isotretinoin can cause irritation.
Not supported by provided label excerpts (no cited “irritation” statement).
Isotretinoin can cause new severe eye pain.
No provided label excerpt supports “new severe eye pain.”
Isotretinoin can cause new or worsening anxiety.
No provided label excerpt supports “anxiety” specifically.
Isotretinoin can cause new or worsening agitation.
No provided label excerpt supports “agitation” specifically.
Isotretinoin can cause severe muscle pain.
Provided label excerpts include joint/muscle pain generally but the specific “severe muscle pain” phrasing is not supported in the supplied evidence.
Isotretinoin can cause persistent vomiting.
No provided label excerpt supports “persistent vomiting” as a specific claim.
Isotretinoin can be associated with signs of dehydration.
No provided label excerpt supports dehydration as a stated sign.
Dryness-related issues often improve after stopping isotretinoin.
Provided excerpts do not support dryness improving after stopping (though some other effects are reversible).
Isotretinoin can cause sun sensitivity, leading to easier sunburn.
No provided label excerpt supports sun sensitivity/easier sunburn.
Using emollients/moisturizers and lip balm regularly may help manage isotretinoin-related dryness.
No provided label excerpt supports this management recommendation.
Using gentle skin care and avoiding harsh products may help manage isotretinoin-related dryness.
No provided label excerpt supports this management recommendation.
Protecting skin from sun with sunscreen and limiting sun exposure may help manage isotretinoin-related sun sensitivity.
No provided label excerpt supports a sunscreen/sun-exposure management recommendation linked to sun sensitivity.
Using artificial tears for dry eyes may help manage isotretinoin-related dry eyes.
No provided label excerpt supports artificial tears as management.
Blistering rash or severe skin peeling during isotretinoin treatment warrants contacting the prescriber promptly.
Provided label excerpts do not specifically link blistering/peeling to contacting the prescriber (only general rash/fever and stop/call for other symptoms are provided).
Extreme fatigue during isotretinoin treatment warrants contacting the prescriber promptly.
No provided label excerpt supports “extreme fatigue” as a stated warning trigger.
Severe or rapidly worsening symptoms during isotretinoin treatment warrant urgent care or emergency services.
No provided label excerpt supports escalation to “urgent care or emergency services” for severe/rapidly worsening symptoms.
Risk of isotretinoin side effects can be higher with higher doses and longer treatment duration.
No provided label excerpt supports dose/duration-dependent higher risk statement.
Risk of isotretinoin side effects can be higher with other medicines that affect the liver or lipids.
No provided label excerpt supports this general risk-modifier statement.
Contradictions
Important Omissions
No claims about the required pregnancy test schedule (two negative tests before initiation and monthly negative pregnancy tests) or monthly iPLEDGE counseling/authorization requirements, despite multiple pregnancy-prevention claims.
Importance:
Moderate
No claim about tetracycline avoidance for pseudotumor cerebri risk (concomitant tetracyclines should be avoided).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
While many serious warnings are correctly reflected, unsupported or overstated management/escalation guidance (e.g., dryness treatments; sun sensitivity; blistering/peeling contact timing; dehydration/fatigue; emergency/urgent escalation) could mislead patients or lead to inappropriate timing of seeking care relative to the label’s documented triggers.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Mostly Aligned
Primary Issue
Several symptom-specific and patient-action/management recommendations are not supported by the provided FDA label excerpts (notably irritation, sun sensitivity/sunburn, emollients/artificial tears/sunscreen management, blistering/peeling contacting guidance, dehydration/fatigue, and emergency/urgent-care escalation).
Suggested Improvement
Remove or rephrase unsupported symptom specificity and management claims unless directly supported in the provided label text; align escalation/stop-and-call triggers strictly to those enumerated in the supplied Medication Guide/Warnings sections.